Medicine for treating nasopharyngeal carcinoma

Abstract

The invention relates to a medicine for treating nasopharyngeal carcinoma. The medicine is prepared from the following medicinal raw materials in parts by weight: 6 parts of alocasia rhizome, 12 parts of rhizoma rehmanniae, 12 parts of radix astragali, 12 parts of fruits of Chinese wolfberry, 7 parts of shinyleaf pricklyash roots, 22 parts of bittersweet herb, 2 parts of fatsia japonica and 6 parts of lotus leaves. According to the medicine disclosed by the invention, the alocasia rhizome is effective on clearing away heat and toxic materials, promoting qi circulation and relieving pain, reducing swelling and resolving mass; the rhizoma rehmanniae is capable of nourishing yin and promoting secretion of saliva; the radix astragali has functions of tonifying qi and activating blood; the fruit of Chinese wolfberry is capable of nourishing liver and kidney; the shinyleaf pricklyash root is effective on relieving swelling and removing toxins; the bittersweet herb is capable of clearing heat and inducing diuresis; the fatsia japonica is capable of removing stasis and relieving pain; and the lotus leaf is effective on sending up lucid yang. By combining the various medicinal raw materials, the medicine has functions of promoting circulation of qi and blood, removing stasis and eliminating stagnation, nourishing yin and promoting secretion of saliva, and clearing away and toxic materials, so that the nasopharyngeal carcinoma can be effectively treated. Clinical experiments prove that the medicine can be used for safely and effectively treating the nasopharyngeal carcinoma.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating nasopharyngeal carcinoma. Background technique [0002] Nasopharyngeal carcinoma refers to malignant tumors that occur on the roof and side walls of the nasopharyngeal cavity. It is one of the high-incidence malignant tumors in my country, and its incidence rate is the first among ear, nose and throat malignant tumors. Common clinical symptoms are nasal congestion, blood in the nasal discharge, ear blockage, hearing loss, diplopia, and headache. Occurs in patients aged 30 to 59, mostly men. Its distribution has certain regional differences and ethnic characteristics, and the incidence rate is high among people of yellow race. It mainly occurs in South China (Guangdong, Guangxi, Hong Kong, Hunan, etc.) and some countries in Southeast Asia (Singapore, Thailand, etc.), and has family aggregation and blood genetic relationship. The pathogenesis of this dis...

AI Technical Summary

Problems solved by technology

[0011] 2. Virus infection

[0015] 3. Environmental factors

[0020] 1. Primary cancer